Cargando…
Which comes first in type 1 diabetes: Autoimmunity or dysglycemia?
A recent study by Warncke et al. suggested that islet autoimmunity is associated with or preceded by insults or changes to the pancreatic islets that impair glucose homeostasis, raising the possibility that β‐cell insult occurs first, followed by autoimmunity to islets.[Image: see text]
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119916/ https://www.ncbi.nlm.nih.gov/pubmed/36722701 http://dx.doi.org/10.1111/jdi.13984 |
| _version_ | 1785029090853519360 |
|---|---|
| author | Ikegami, Hiroshi |
| author_facet | Ikegami, Hiroshi |
| author_sort | Ikegami, Hiroshi |
| collection | PubMed |
| description | A recent study by Warncke et al. suggested that islet autoimmunity is associated with or preceded by insults or changes to the pancreatic islets that impair glucose homeostasis, raising the possibility that β‐cell insult occurs first, followed by autoimmunity to islets.[Image: see text] |
| format | Online Article Text |
| id | pubmed-10119916 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101199162023-04-22 Which comes first in type 1 diabetes: Autoimmunity or dysglycemia? Ikegami, Hiroshi J Diabetes Investig Commentary A recent study by Warncke et al. suggested that islet autoimmunity is associated with or preceded by insults or changes to the pancreatic islets that impair glucose homeostasis, raising the possibility that β‐cell insult occurs first, followed by autoimmunity to islets.[Image: see text] John Wiley and Sons Inc. 2023-02-01 /pmc/articles/PMC10119916/ /pubmed/36722701 http://dx.doi.org/10.1111/jdi.13984 Text en © 2023 The Author. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Commentary Ikegami, Hiroshi Which comes first in type 1 diabetes: Autoimmunity or dysglycemia? |
| title | Which comes first in type 1 diabetes: Autoimmunity or dysglycemia? |
| title_full | Which comes first in type 1 diabetes: Autoimmunity or dysglycemia? |
| title_fullStr | Which comes first in type 1 diabetes: Autoimmunity or dysglycemia? |
| title_full_unstemmed | Which comes first in type 1 diabetes: Autoimmunity or dysglycemia? |
| title_short | Which comes first in type 1 diabetes: Autoimmunity or dysglycemia? |
| title_sort | which comes first in type 1 diabetes: autoimmunity or dysglycemia? |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119916/ https://www.ncbi.nlm.nih.gov/pubmed/36722701 http://dx.doi.org/10.1111/jdi.13984 |
| work_keys_str_mv | AT ikegamihiroshi whichcomesfirstintype1diabetesautoimmunityordysglycemia |